The Defeat Parkinson's Platform Tübingen
Parkinson’s disease (PD) is one of the most devastating neurodegenerative conditions. Although dopamine replacement treatment or deep brain stimulation can give remarkable temporary benefit to many patients, there is still no cure and it is not yet possible to significantly slow the progression of the disease.
However, in recent years we have seen a remarkable progress in the understanding of the genetic, molecular and cellular underpinnings of the disorder, and new treatments may be within reach in the not too distant future.
Supported by a major private donation and research grants from the MJFF and EU worth more than 2,5 Million Euro, the Hertie Institute for Clinical Brain Research and the German Center for Neurodegenerative Diseases (DZNE) in Tübingen have established the Defeat Parkinson’s Research Platform. Clinical and pre-clinical researchers will be joining forces to use cutting edge molecular, genetic, cell biologic and computational technologies to better understand the complex mechanisms underlying the disorder and to develop novel biomarkers and treatments.
